Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yixun Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1758-0948; OpenAlex author ID A5018085509. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-catenin. Co-author DOI 10.1016/j.gendis.2024.101382↗
  2. Targeting MTPN sensitizes pancreatic cancer of wild-type BRCA1/2 to Cisplatin-based chemotherapy. Co-author DOI 10.1038/s41417-025-00925-5↗
  3. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.827051↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lifu Wang · 3 shared papers, 2022–2025 · strength 0.72
  2. Zhuoxin Wang · 3 shared papers, 2022–2025 · strength 0.72
  3. Xinyang Huang · 2 shared papers, 2022–2025 · strength 0.47
  4. Qi Wang · 2 shared papers, 2022–2025 · strength 0.47
  5. Qi Wang · 1 shared paper, 2025 · strength 0.26
  6. Tingting Gong · 1 shared paper, 2025 · strength 0.26
  7. Liangchao Zhao · 1 shared paper, 2022 · strength 0.16
  8. Hui Xu · 1 shared paper, 2022 · strength 0.16
  9. Tong Li · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.